Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :28930164
Publication Date : 2017/09/20

Liver Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells.


Liver cancer is the second most common cause of cancer-related death. The major forms of primary liver cancer are hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (iCCA). Both these tumors develop against a background of cirrhotic liver, non-alcoholic fatty liver disease, chronic liver damage and fibrosis. HCC is a heterogeneous disease which usually develops within liver cirrhosis related to various etiologies: hepatitis B virus (HBV) infection (frequent in Asia and Africa), hepatitis C virus (HCV), chronic alcohol abuse, or metabolic syndrome (frequent in Western countries). In cirrhosis, hepatocarcinogenesis is a multi-step process where pre-cancerous dysplastic macronodules transform progressively into HCC. The patterns of genomic alterations observed in these tumors were recently identified and were instrumental for the identification of potential targeted therapies that could improve patient care. Liver cancer stem cells are a small subset of undifferentiated liver tumor cells, responsible for cancer initiation, metastasis, relapse and chemoresistance, enriched and isolated according to immunophenotypic and functional properties: cell surface proteins (CD133, CD90, CD44, EpCAM, OV-6, CD13, CD24, DLK1, α2δ1, ICAM-1 and CD47); the functional markers corresponding to side population, high aldehyde dehydrogenase (ALDH) activity and autofluorescence. The identification and definition of liver cancer stem cells requires both immunophenotypic and functional properties.

Authors : Castelli Germana , Pelosi Elvira , Testa Ugo ,

Related products :

Catalog number Product name Quantity
Liver - LVC481 Liver cancer tissue array, 16 cases of liver cancer, each in duplicates, paired with corresponding uninvolved tissues from the same patients 2mm
Liver - LVC1502 Liver cancer array, non_overlapping with LVC1501, consists of duplicated 70 cases covering all the common types of liver cancer and 5 cases of normal and other non_malignant liver tissues. 1.1mm
Liver - LVC1501 Liver cancer array consists of duplicated 70 cases covering all the common types of liver cancer and 5 cases of normal and other non_malignant liver tissues. 1.1mm
Liver - LVC961 Liver cancer array consists of duplicated 36 cases covering all the common types of liver cancer and 12 cases of normal and other non_malignant liver tissues. 1.5mm
MG-0018-100 Liver Cancer Stem Cell Multiplex PCR 100
MG-0018-50 Liver Cancer Stem Cell Multiplex PCR 50
LV803 Liver carcinoma (combination of cancer, cancer adjacent and normal tissue), 53 cases_72 cores, replacing BC03021
9-80038 Human Cancer PrimaCell™15: Skin Cancer Cells, primary cell culture 1 x 100 ml
9-46038 Human Cancer PrimaCell™15: Skin Cancer Cells, primary cell culture 5 x 100 ml
2-96038 Human Cancer PrimaCell™15: Skin Cancer Cells, primary cell culture Kit
4-28038 Human Cancer PrimaCell™15: Skin Cancer Cells, primary cell culture Kit
9-47038 Human Cancer PrimaCell™15: Skin Cancer Cells, primary cell culture set
5-81014 Human hepatoma cells, male, 62, primary liver cancer vial
778 Liver cancer and cancer adjacent normal tissue array, including TNM, clinical stage and pathology grade, 80 cases_80 cores, replacing LV801
LV803 Liver carcinoma (combination of cancer, cancer adjacent and normal tissue), 53 cases_72 cores, replacing BC03021; ihc Anti-Alpha Fetoprotein (AFP) confirmed
2-96033 Human Cancer PrimaCell™10: Liver Tumor Cells, primary cell culture Kit
9-46033 Human Cancer PrimaCell™10: Liver Tumor Cells, primary cell culture 5 x 100 ml
4-28033 Human Cancer PrimaCell™10: Liver Tumor Cells, primary cell culture Kit
9-80033 Human Cancer PrimaCell™10: Liver Tumor Cells, primary cell culture 1 x 100 ml
9-47033 Human Cancer PrimaCell™10: Liver Tumor Cells, primary cell culture set
779 Liver cancer tissue array with cancer adjacent normal tissue as control, including TNM, clinical stage and pathology grade, 80cases_ 80cores, replacing LV802
27-292 TSC22D4 is a leucine zipper-containing protein that is highly conserved during evolution. It is transcriptionally up-regulated by many different stimuli, including anti-cancer drugs and growth inhibit 0.1 mg
Liver - LVC962 Liver cancer tissue array, non_overlapping with LVC961, including 48 cases of uninvolved and cancerous tissues of the liver in duplicates. Coming soon. 1.5mm
orb82297 Cancer Ag CA19-9 Calib. Grade protein Cancer Antigen CA19-9 (Gastrointestinal Cancer) Calibrator Grade is a purified reagent for cancer research. For research use only. 50 KU
orb61244 Erlotinib Erlotinib hydrochloride is a drug used to treat non-small cell lung cancer, pancreatic cancer and several other types of cancer. For research use only. 100 mg


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur